|Articles|December 11, 2020
- Pharmaceutical Executive-12-01-2020
- Volume 40
- Issue 12
Pharmaceutical Executive, December 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 5 years ago
For Investors, ’Tis the Season to be Gratefulalmost 5 years ago
A ‘Sign’ of the Times: Digital Contract Transformationalmost 5 years ago
Opening Digital Doors: Remote Selling During COVID-19almost 5 years ago
The C-Suite’s Frontline Workers in Digital Changealmost 5 years ago
Guiding Advice for Leaders Through COVID and Beyondalmost 5 years ago
EU Under Pressure to Make Decisions on Data Sharingalmost 5 years ago
COVID and AMR: Crisis Reframes Antibiotics Fightalmost 5 years ago
Here’s to Looking AheadNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
